Identifying and verifying Huntington's disease subtypes: Clinical features, neuroimaging, and cytokine changes
Brain and Behavior · 2024-03 · 14 (3)
DOI: 10.1002/brb3.3469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 17.03.2024. Verfasst von Ling-Xiao Cao und 4 weiteren Autor:innen. Beteiligte Einrichtung: China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Huntington Disease, Chorea. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing E-town Cooperation & Development Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
Huntington's disease (HD) is a progressive neurodegenerative disorder with heterogeneous clinical manifestations. Identifying distinct clinical clusters and their relevant biomarkers could elucidate the underlying disease pathophysiology.
Methods
Following the Enroll‐HD program initiated in 2018.09, we have recruited 104 HD patients (including 21 premanifest) and 31 health controls at Beijing Tiantan Hospital. Principal components analysis and k‐means cluster analysis were performed to determine HD clusters. Chi‐square test, one‐way ANOVA, and covariance were used to identify features among these clusters. Furthermore, plasma cytokines levels and brain structural imaging were used as biomarkers to delineate the clinical features of each cluster.
Results
Three clusters were identified. Cluster 1 demonstrated the most severe motor and nonmotor symptoms except for chorea, the lowest whole brain volume, the plasma levels of IL‐2 were higher and significantly associated with cluster 1. Cluster 2 was characterized with the most severe chorea and the largest pallidum volume. Cluster 3 had the most benign motor symptoms but moderate psychiatric problems.
Conclusion
We have identified three HD clusters via clinical manifestations with distinct biomarkers. Our data shed light on better understanding about the pathophysiology of HD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Neurology, The Third People's Hospital of Longgang District, Shenzhen, China.
- Pharmacology Department, School of Biomedical Sciences, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia.
ORCID-Profile: Yue Huang
Förderung
- Beijing E-town Cooperation & Development Foundation
- National Natural Science Foundation of China
Zitieren
APA
Cao, L. X., Yin, J. H., Du, G., Yang, Q., & Huang, Y. (2024). Identifying and verifying Huntington's disease subtypes: Clinical features, neuroimaging, and cytokine changes. Brain and Behavior, 14(3). https://doi.org/10.1002/brb3.3469
Vancouver
Cao LX, Yin JH, Du G, Yang Q, Huang Y. Identifying and verifying Huntington's disease subtypes: Clinical features, neuroimaging, and cytokine changes. Brain and Behavior. 2024;14(3). doi:10.1002/brb3.3469
BibTeX
@article{Cao2024,
author = {Cao, Ling-Xiao and Yin, Jin-Hui and Du, Gang and Yang, Qing and Huang, Yue},
title = {Identifying and verifying Huntington's disease subtypes: Clinical features, neuroimaging, and cytokine changes},
journal = {Brain and Behavior},
year = {2024},
volume = {14},
number = {3},
doi = {10.1002/brb3.3469}
}
EUVIMED